- Home
- Cardio-renal-metabolic UK Annual Meeting 2024 sessions
CVRM medicine: Taking a holistic approach
In this CVRM meeting session, Dr. Kevin Fernando highlighted the interconnectedness of cardiovascular, renal, and metabolic conditions, emphasising how dysfunction in one area drives dysfunction in others. He referenced various guidelines, including NG28, NG203, and the 2023 ESC guidelines, as well as key takeaways from KDIGO 2022 and 2024. Dr. Fernando stressed the importance of delivering healthcare in a holistic, person-centered manner, advocating for a shift away from a disease-centred approach.
CVRM medicine: Taking a new approach to existing cardiovascular challenges
In this CVRM meeting session, Dr. Joe Martins shed light on the pressing challenges posed by cardiovascular disease and advocated for a comprehensive management approach. He emphasised the significance of addressing atherosclerosis, drawing from the REACH study to highlight the importance of healthcare providers prioritising holistic vascular system management over singular condition focus. Additionally, Dr. Martins delved into treatment options and outlined the four key therapeutic pillars of vascular protection.
Type 2 diabetes: exploring the metabolic consequences
In this CVRM meeting session, Professor David Strain emphasised the rapid evolution of evidence, particularly evident in the evolving approach to diabetes management from 2007 to the present. He highlighted the importance of considering metabolic associated fatty liver disease (MASLD) within CVRM conditions and shared strategies for addressing the metabolic consequences of type 2 diabetes.
Metabolic dysfunction-associated steatotic liver disease (MASLD) – a threat to public health?
In this CVRM meeting session, Dr. Kevin Fernando stressed the significance of acknowledging and tackling metabolic dysfunction-associated steatotic liver disease (MASLD), noting that it stems from metabolic issues rather than being solely a liver ailment. He also provided insights into tools and resources available to healthcare providers, along with lifestyle modification interventions, to address MASLD effectively.
Leadership and change management: Lessons from type 1 diabetes
In this CVRM meeting session, Professor Partha Kar delivered an engaging presentation on leadership and change management, drawing lessons from the landscape of type 1 diabetes management. He advocated for open and public leadership that genuinely engages with and empowers the affected communities. Professor Kar encouraged delegates to set ambitious goals and pursue challenges others might deem impossible.
CVRM medicine: Interdisciplinary view
In this CVRM meeting session, Dr Brendon Neuen discussed the convergence of guidelines-directed medical therapy (GDMT) for heart failure and chronic kidney disease and proposed an "accelerated risk-based approach" for kidney GDMT implementation while recognising barriers along the care pathway. Additionally, Dr. Muthu Vaduganathan emphasised the significance of implementation strategies in bridging the gap between knowledge and action in CVRM to enhance patient outcomes.